Article
Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.
The Journal of antimicrobial chemotherapy - 1 May 2016
Adler Marlen, Anjum Mehreen, Andersson Dan I, Sandegren Linus
Abstract excerpt
OBJECTIVES: The worldwide spread of ESBL-producing Enterobacteriaceae has led to an increased use of carbapenems, the group of β-lactams with the broadest spectrum of activity. Bacterial resistance to carbapenems is mainly due to acquired carbapenemases or a combination of ESBL production and reduced drug influx via loss of outer-membrane porins. Here, we have studied the development of carbapenem resistance in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
